Overview of the management of atrial fibrillation: what is the current state of the art? (Q35684050)

9 August 2017

1 reference

title

Overview of the management of atrial fibrillation: what is the current state of the art? (English)

1 reference

9 August 2017

1 reference

Peter R Kowey

1

1 reference

9 August 2017

Gan-Xin Yan

series ordinal

2

1 reference

9 August 2017

Tara L Dimino

series ordinal

3

1 reference

9 August 2017

Dusan Z Kocovic

series ordinal

4

1 reference

9 August 2017

publication date

1 December 2003

1 reference

Journal of Cardiovascular Electrophysiology

9 August 2017

published in

1 reference

9 August 2017

volume

14

1 reference

9 August 2017

issue

12 Suppl

1 reference

9 August 2017

page(s)

S275-80; discussion S280

1 reference

Drug choices in the treatment of atrial fibrillation

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Antiarrhythmic agents in facilitating electrical cardioversion of atrial fibrillation and promoting maintenance of sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Independent predictive factors of acute and first year success after electrical cardioversion in patients with chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Ibutilide-induced long QT syndrome and torsade de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Acute treatment of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Value of precardioversion transesophageal echocardiography in managing cardioversion in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Use of low-molecular-weight heparin as bridge anticoagulation therapy in patients with atrial fibrillation undergoing transoesophageal echocardiography guided cardioversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Risk Factors for Stroke in Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Atrial fibrillation--rhythm or rate control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Efficacy of biphasic waveform cardioversion for atrial fibrillation and atrial flutter compared with conventional monophasic waveforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.90405.X

10.1046/J.1540-8167.2003.90405.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference